[1] Hsu C, Tsou HH, Lin SJ, et al. Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: a prospective study. Hepatology, 2014, 59: 2092-2100.
[2] 中华医学会肝病学分会,中华医学会感染病学分会. 慢性乙型肝炎防治指南(2015年版).中国肝脏病杂志(电子版),2015, 7:1-18.
[3] 中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2012年版). 中华肝脏病杂志,2013, 21:177-183.
[4] Watanabe T, Tanaka Y. Reactivation of hepatitis viruses following immunomodulating systemic chemotherapy. Hepatol Res, 2013, 43: 113-121.
[5] Tsutsumi Y, Yamamoto Y, Shimono J, et al. Hepatitis B virus reactivation with rituximab-containing regimen. World J Hepatol, 2013, 5: 612-620.
[6] Kusumoto S, Tanaka Y, Mizokami M, et al. Reactivation of hepatitis B virus following systemic chemotherapy for malignant lymphoma. Int J Hematol, 2009, 90: 13-23.
[7] Kim SJ, Hsu C, Song YQ, et al. Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: analysis from the Asia Lymphoma Study Group. Eur J Cancer, 2013, 49: 3486-3496. |
